Gregory L. Weaver, Chief Financial Officer at PONIARD PHARMACEUTICALS, INC. (PARD), bought 3,000 shares at $7.39 ($22K) on 2009-08-21, disclosed to the SEC on 2009-08-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.39 | 2,100 | $16K | 70.0% |
| 2 | $7.40 | 900 | $7K | 30.0% |
| Total | $7.39 avg | 3,000 | $22K | 100% |
| Filing → |
| ALT | BUY | 2025-03-14 | $52K | — | Filing → |
| ATOS | SELL | 2023-11-17 | $33K | — | Filing → |
| ATOS | BUY | 2023-06-20 | $49K | — | Filing → |